DNLI — DENALI THERAPEUTICS INC
As of Q2 2026, 34 SEC-registered investment managers reported holding DNLI (DENALI THERAPEUTICS INC) in their latest 13F filings, with a combined reported value of $1.76B across 71.41M shares. That is +9.3% by share count (+6.08M shares) versus the previous quarter, while reported value moved +45.5%. Ownership is concentrated: the five largest holders account for 61.1% of reported value and the top ten for 82.3%.
Compared with the prior quarter, 1 opened new positions, 21 added to existing stakes, 11 trimmed, 3 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
DNLI is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| BlackRock Inc history | Q2 2026 | 14.03M | $360.76M | 0.01% | Add |
| Baillie Gifford & Co history | Q2 2026 | 11.96M | $307.62M | 0.28% | Reduce |
| Vanguard Group history | Q4 2025 | 13.06M | $215.59M | 0.00% | Add |
| Temasek Holdings history | Q2 2026 | 7.01M | $180.37M | 0.51% | Hold |
| Fidelity Management & Research (FMR) history | Q2 2026 | 4.54M | $116.66M | 0.01% | Reduce |
| Goldman Sachs Group history | Q2 2026 | 4.16M | $106.89M | 0.01% | Reduce |
| Geode Capital Management history | Q2 2026 | 3.97M | $102.21M | 0.01% | Add |
| UBS Group AG history | Q2 2026 | 3.12M | $80.26M | 0.01% | Add |
| Norges Bank Investment Management history | Q2 2026 | 2.82M | $72.65M | 0.01% | Reduce |
| Capital Research Global Investors history | Q2 2026 | 2.57M | $65.99M | 0.01% | Add |
| Casdin Capital history | Q2 2026 | 2.04M | $52.60M | 2.63% | Add |
| Principal Global Investors history | Q2 2026 | 1.42M | $36.52M | 0.02% | Reduce |
| Northern Trust Corp history | Q2 2026 | 1.39M | $35.74M | 0.00% | Add |
| Charles Schwab Investment Management history | Q2 2026 | 1.24M | $32.02M | 0.00% | Add |
| Bank of America Corp history | Q2 2026 | 1.23M | $31.66M | 0.00% | Add |
| Millennium Management history | Q2 2026 | 1.13M | $28.95M | 0.01% | Reduce |
| Morgan Stanley history | Q2 2026 | 961.05K | $24.72M | 0.00% | Reduce |
| BNY Mellon history | Q2 2026 | 800.28K | $20.58M | 0.00% | Add |
| Citadel Advisors history | Q2 2026 | 600.07K | $15.43M | 0.00% | Add |
| Marshall Wace history | Q2 2026 | 549.83K | $14.14M | 0.01% | Reduce |
New Positions (Q2 2026)
- JPMorgan Chase & Co 287.02K sh · $7.59M
Fully Exited (vs previous quarter)
- Polen Capital Management sold 65.30K sh · $1.25M
- Janus Henderson Group sold 60.03K sh · $1.15M
- Amundi US sold 18.60K sh · $357.20K
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q3 2021 | Q4 2021 | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BlackRock Inc | — | — | — | — | — | — | — | — | — | — | — | — | 13.79M | 13.92M | 13.83M | 12.05M | 12.29M | 12.72M | 13.03M | 14.03M |
| Baillie Gifford & Co | 15.01M | 15.06M | 14.98M | 14.87M | 14.72M | 15.12M | 15.35M | 14.84M | 14.68M | 14.26M | 14.04M | 13.76M | 13.35M | 12.31M | 12.09M | 11.96M | 11.59M | 12.31M | 12.07M | 11.96M |
| Temasek Holdings | 5.37M | 5.37M | 5.37M | 5.37M | 5.58M | 6.52M | 6.90M | 6.90M | 6.90M | 6.90M | 5.71M | 5.71M | 5.36M | 5.36M | 5.36M | 5.36M | 5.36M | 7.01M | 7.01M | 7.01M |
| Fidelity Management & Research (FMR) | 2.68M | 2.95M | 2.94M | 2.87M | 2.45M | 2.21M | 1.09M | 1.08M | 1.06M | 641.65K | 1.23M | 234.87K | 7.83M | 8.02M | 7.41M | 7.54M | 6.34M | 6.10M | 4.58M | 4.54M |
| Goldman Sachs Group | 1.06M | 410.76K | 406.23K | 420.74K | 728.27K | 771.45K | 572.84K | 644.91K | 407.39K | 393.81K | 904.36K | 1.22M | 1.37M | 1.06M | 1.67M | 1.87M | 2.16M | 3.84M | 4.41M | 4.16M |
| Geode Capital Management | 1.61M | 1.63M | 1.63M | 1.71M | 1.78M | 2.05M | 2.15M | 2.32M | 2.53M | 2.66M | 2.76M | 2.98M | 2.96M | 2.94M | 3.04M | 3.17M | 3.47M | 3.46M | 3.73M | 3.97M |
| UBS Group AG | 64.48K | 92.35K | 39.11K | 6.38K | 42.45K | 120.18K | 127.35K | 131.94K | 109.70K | 290.99K | 343.88K | 136.22K | 141.40K | 852.86K | 788.43K | 950.76K | 2.01M | 2.40M | 2.57M | 3.12M |
| Norges Bank Investment Management | — | — | — | — | — | 1.02M | — | — | — | 1.15M | — | 823.94K | — | 1.07M | — | 3.95M | — | 5.12M | — | 2.82M |
| Capital Research Global Investors | — | — | — | — | 87.77K | 2.26M | 2.47M | 2.84M | 2.88M | 2.91M | 6.05M | 7.13M | 7.91M | 5.48M | 4.77M | 4.75M | 4.76M | 3.73M | 2.51M | 2.57M |
| Casdin Capital | 1.70M | 1.50M | 1.50M | 1.50M | 995.00K | 1.30M | 1.30M | 1.30M | 1.30M | 1.30M | 1.30M | 1.30M | 990.00K | 990.00K | 990.00K | 890.00K | 890.00K | 1.84M | 1.84M | 2.04M |
| Principal Global Investors | 303.83K | 330.27K | 269.00K | 267.73K | 545.87K | 526.46K | 488.96K | 686.49K | 680.08K | 1.07M | 1.12M | 1.09M | 1.24M | 1.13M | 1.08M | 1.07M | 1.27M | 1.52M | 1.48M | 1.42M |
| Northern Trust Corp | 951.73K | 959.09K | 906.23K | 890.62K | 889.97K | 984.19K | 1.02M | 1.09M | 1.12M | 1.10M | 1.09M | 1.08M | 1.09M | 1.20M | 1.13M | 1.20M | 1.23M | 1.20M | 1.31M | 1.39M |
| Charles Schwab Investment Management | 703.75K | 717.19K | 704.25K | 731.52K | 730.88K | 836.67K | 836.33K | 867.63K | 981.06K | 1.01M | 1.04M | 1.06M | 1.02M | 1.03M | 1.01M | 1.06M | 1.15M | 1.20M | 1.21M | 1.24M |
| Bank of America Corp | 77.85K | 128.95K | 241.24K | 119.07K | 220.22K | 334.77K | 419.84K | 270.25K | 295.79K | 458.64K | 851.98K | 742.05K | 348.16K | 270.33K | 447.76K | 650.22K | 961.14K | 932.14K | 1.13M | 1.23M |
| Millennium Management | 41.84K | 18.36K | — | 645.34K | 496.18K | 297.09K | 386.29K | 478.19K | 118.35K | — | 390.62K | 619.93K | 60.17K | 404.22K | 1.49M | 900.50K | 1.31M | 369.77K | 1.27M | 1.13M |
| Morgan Stanley | 383.99K | 287.26K | 705.65K | 423.01K | 681.33K | 432.49K | 569.12K | 1.08M | 981.57K | 977.49K | 928.13K | 1.22M | 1.74M | 1.23M | 1.25M | 1.31M | 1.69M | 1.22M | 1.10M | 961.05K |
| BNY Mellon | 376.72K | 932.59K | 1.61M | 1.87M | 1.90M | 2.01M | 2.02M | 1.99M | 1.96M | 1.87M | 1.78M | 1.54M | 1.33M | 1.24M | 1.10M | 790.76K | 800.75K | 762.09K | 768.04K | 800.28K |
| Citadel Advisors | 103.71K | 538.28K | 761.20K | 332.40K | 86.54K | 69.21K | 1.41M | 67.40K | 76.11K | 77.21K | 1.39M | 1.24M | 796.38K | 856.11K | 1.20M | 1.28M | 699.82K | 806.25K | 351.02K | 600.07K |
| Marshall Wace | 531.36K | 383.94K | 152.85K | 817.65K | 675.87K | 960.64K | 350.54K | — | — | 1.67M | 2.15M | 2.42M | 1.97M | 1.79M | 2.19M | 1.41M | 787.03K | 763.89K | 991.27K | 549.83K |
| Citigroup Inc | 109.03K | 120.38K | 35.38K | 111.81K | 192.64K | 128.12K | 208.34K | 108.03K | 138.31K | 141.28K | 382.42K | 104.45K | 94.71K | 166.71K | 194.00K | 76.31K | 14.94K | 30.95K | 99.28K | 487.28K |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details